InvestorsHub Logo
Followers 16
Posts 5821
Boards Moderated 0
Alias Born 07/16/2018

Re: abew4me post# 290493

Monday, 12/28/2020 6:22:45 PM

Monday, December 28, 2020 6:22:45 PM

Post# of 457188
WHY WOULD THE FDA BE INVOLVED WITH THE "SPECIFIC GUIDELINES" OF AN "AUSTRALIAN CLINICAL STUDY"???????

Thanks Investor. I assume that Anavex needed time to meet with the FDA (to get specific guidelines for the next trial) before they could request funding from the Shake-It-Up Foundation.

Is that your take as well?

"In August 2020, we announced a financial commitment by Shake It Up Australia Foundation (SIUAF) for Parkinson’s Research to fund up to 50% of the costs of an Australian clinical study to develop ANAVEX®2-73 for the disease modifying treatment of Parkinson’s disease. The financial commitment would be made through private placement purchases of our common stock at 200% of the fair market value on the purchase date and will be contingent upon the completion of certain clinical trial milestones relating to the proposed clinical trial. There was no impact on our consolidated financial statements for the year ended September 30, 2020 as a result of the commitment from SIUAF."



GOOD LUCK AND GOD BLESS!!!!

"The deepest sin against the human mind is to believe things without evidence." - Aldous Huxley


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News